BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hematopoietic cell
,
Quercetin
,
rs3825942
,
LEP
,
Metabolism of xenobiotics
,
Ischemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Plzf
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Nipple cross-section
Skeletal muscle
Lung
Coronary artery
Pericardium
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Viral enteritis
Intestinal infectious disease
Drug resistance
Chronic sinusitis
Body fat finding
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Selenium
Smoking, Passive
Bucladesine
Chloroprene
trilinolenin
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
USP7
ZBTB16
GTF2A2
GRK2
ABCA1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Inflammasome activity is controlled by ZBTB16-dependent SUMOylation of ASC.
Zbtb16 increases susceptibility of atrial fibrillation in type 2 diabetic mice via Txnip-Trx2 signal…
Progranulin regulates the development and function of NKT2 cells through EZH2 and PLZF.
Zbtb16 regulates social cognitive behaviors and neocortical development.
Long non-coding RNA ELFN1-AS1-mediated ZBTB16 inhibition augments the progression of gastric cancer …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Systemic Sclerosis and Innate T Cells
5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS
Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Da…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ